MAP3K5 and benign prostatic hyperplasia: Results of microarrays in prostate tissue samples are similar (Fig. S8A, B), where the expression levels of AKR1C2 and TXNRD1 were significantly lower, and MAP3K5 expression level was significantly higher in BPH samples (Fig. S8C).